Search results
Jun 20, 2024 · Dr. Moncef Slaoui was most recently the Chief Scientific Advisor to Operation Warp Speed. Under his leadership the operation enabled the fastest ever development, manufacturing, and approval of...
Jun 20, 2024 · Dr. Moncef Slaoui was most recently the Chief Scientific Advisor to Operation Warp Speed. Under his leadership the operation enabled the fastest ever development, manufacturing, and approval of multiple COVID-19 vaccines in less than 11 months after the virus genetic sequence was described.
Jun 20, 2024 · Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors. Previously Chief Scientific Advisor for Operation Warp Speed, advised U.S. President's Council of Advisors on Science...
Jun 21, 2024 · → Moncef Slaoui has reemerged this week with another board appointment, making his way to mRNA drug developer Arcturus Therapeutics. Endpoints News scooped you last September on Slaoui’s board seat with Altesa BioSciences , an antiviral startup with former HHS official Brett Giroir as CEO.
Jun 21, 2024 · → Moncef Slaoui has reemerged this week with another board appointment, making his way to mRNA drug developer Arcturus Therapeutics. …
Jun 20, 2024 · Slaoui, recognized for his leadership in Operation Warp Speed and his tenure at GlaxoSmithKline (NYSE: GSK), brings extensive experience in pharmaceutical innovation and vaccine development...
People also ask
Who is Moncef Slaoui?
Who is Dr Slaoui?
How long has Dr Slaoui been at GlaxoSmithKline?
Jun 20, 2024 · Privacy Policy. © 2024 Arcturus Therapeutics, Inc.